During the past decade, Thalassemia Center San Luigi Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Thalassemia Center San Luigi Hospital" are "Iron Overload Due to Repeated Red Blood Cell Transfusions" (2 trials), "Transfusional Iron Overload" (2 trials), "Beta-Thalassemia" (1 trials) and "Beta-thalassemia" (1 trials). Many other conditions were trialed in "Thalassemia Center San Luigi Hospital" in a lesser frequency.

Most popular intervention types in "Thalassemia Center San Luigi Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "SPD602" (2 trials), "SPD602 (FBS0701, SSP-004184)" (1 trials) and "SSP-004184AQ" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thalassemia Center San Luigi Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Thalassemia Center San Luigi Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Thalassemia Center San Luigi Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Thalassemia Center San Luigi Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".